scispace - formally typeset
A

Attila Garami

Researcher at Max Planck Society

Publications -  6
Citations -  1318

Attila Garami is an academic researcher from Max Planck Society. The author has contributed to research in topics: Mutant & Mannose. The author has an hindex of 5, co-authored 5 publications receiving 1251 citations. Previous affiliations of Attila Garami include Novartis & Friedrich Miescher Institute for Biomedical Research.

Papers
More filters
Journal ArticleDOI

Insulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2

TL;DR: Evidence is provided that TSC1/2 is a GAP for the small GTPase Rheb and that insulin-mediated RheB activation is PI3K dependent and that Rhe b overexpression induces S6K1 phosphorylation and inhibits PKBosphorylation, as do loss-of-function mutations in TSC 1/2.
Journal ArticleDOI

Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability

TL;DR: It is demonstrated that GDP‐mannose biosynthesis is not essential for Leishmania viability in culture, but constitutes a virulence pathway in these human pathogens.
Journal ArticleDOI

Glycosylation Defects and Virulence Phenotypes of Leishmania mexicana Phosphomannomutase and Dolicholphosphate-Mannose Synthase Gene Deletion Mutants

TL;DR: Man activation leading to GDP-Man as a virulence pathway in Leishmania is defined as a result against expectation and in contrast to the lethal phenotype observed in gene deletion experiments with fungi.
Journal ArticleDOI

The Role of Phosphomannose Isomerase in Leishmania mexicana Glycoconjugate Synthesis and Virulence

TL;DR: The cloned PMI gene from Leishmania mexicana provides the first conditional mannose-controlled system for parasite glycoconjugate assembly with potential applications for the investigation of their biosynthesis, intracellular sorting, and function.
Journal ArticleDOI

Characterisation of a Leishmania mexicana knockout lacking guanosine diphosphate-mannose pyrophosphorylase.

TL;DR: Surprisingly, in view of the lack of several known host-protective antigens, injection of the mutant parasites into BALB/c mice confers significant and long lasting protection against infection, suggesting that these temperature sensitive mutants are an attractive candidate for a live attenuated vaccine.